Abstract:Background: Mutations in recombination-activating gene (RAG) 1 and RAG2 are associated with a broad range of clinical and immunologic phenotypes in human subjects. Objective: Using a flow cytometry-based assay, we aimed to measure the recombinase activity of naturally occurring RAG2 mutant proteins and to correlate our results with the severity of the clinical and immunologic phenotype. Methods: Abelson virus-transformed Rag2-/- pro-B cells engineered to contain an inverted green fluorescent protein (GFP) cassette flanked by recombination signal sequences were transduced with retroviruses encoding either wild-type or 41 naturally occurring RAG2 variants. Bicistronic vectors were used to introduce compound heterozygous RAG2 variants. The percentage of GFP-expressing cells was evaluated by using flow cytometry, and high-throughput sequencing was used to analyze rearrangements at the endogenous immunoglobulin heavy chain (Igh) locus. Results: The RAG2 variants showed a wide range of recombination activity. Mutations associated with severe combined immunodeficiency and Omenn syndrome had significantly lower activity than those detected in patients with less severe clinical presentations. Four variants (P253R, F386L, N474S, and M502V) previously thought to be pathogenic were found to have wild-type levels of activity. Use of bicistronic vectors permitted us to assess more carefully the effect of compound heterozygous mutations, with good correlation between GFP expression and the number and diversity of Igh rearrangements. Conclusions: Our data support genotype-phenotype correlation in the setting of RAG2 deficiency. The assay described can be used to define the possible disease-causing role of novel RAG2 variants and might help predict the severity of the clinical phenotype.

The R229Q mutation of Rag2 does not characterize severe immunodeficiency in mice

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

Hypomorphic mutation in the RAG2 gene affects dendritic cell distribution and migration

Biological Characteristics of Severe Combined Immunodeficient Mice Produced by CRISPR/Cas9-Mediated Rag2 and IL2rg Mutation

RAG-1-deficient mice have no mature B and T lymphocytes

Disruption of the RAG2 zinc finger motif impairs protein stability and causes immunodeficiency

RAG1 splicing mutation causes enhanced B cell differentiation and autoantibody production

Aberrant Alternative Splicing in U2af1/Tet2 Double Mutant Mice Contributes to Major Hematological Phenotypes

Clinical, Immunologic, and Genetic Characteristics of RAG Mutations in 15 Chinese Patients with SCID and Omenn Syndrome.

Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype

Rag2 Deficiency Enhances Susceptibility to Systemic Mouse Adenovirus Type 1 Infection

Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences

Generation of Recombination Activating Gene-1-Deficient Neonatal Piglets: A Model of T and B Cell Deficient Severe Combined Immune Deficiency

Whole-exome sequencing identified a homozygous novel RAG1 mutation in a child with omenn syndrome

iPSC-Based Modeling of RAG2 Severe Combined Immunodeficiency Reveals Multiple T Cell Developmental Arrests

Analysis of Regulatory CD8 T Cells in Qa-1-deficient Mice

The RAG cell line defines a new complementation group of MHC class II deficiency

From variant of uncertain significance to likely pathogenic in two siblings with atypical RAG2 Deficiency: a case report and review of the literature

RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches

Novel RAG1 mutation and the occurrence of mycobacterial and Chromobacterium violaceum infections in a case of leaky SCID

Construction of severe combined immunodeficiency mice based on CRSIPR/Cas9 technology